CEL-SCI’s Chief Scientific Officer Discusses Cancer Immunotherapy Multikine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. PRY:IM
5. PRYMY
6. SKA-B
7. PBA
8. CCH:LN
9. META
10. CCHGY

Go back to CEL-SCI’s Chief Scientific Officer Discusses Cancer Immunotherapy Multikine
CEL-SCI CORPORATION (NYSE: CVM) Delayed: 1.14 +0.09 (8.57%)
Previous Close $1.05    52 Week High $0.66 
Open $1.06    52 Week Low $0.20 
Day High $1.17    P/E N/A 
Day Low $1.06    EPS $-0.34 
Volume 658,535       

CEL-SCI CORPORATION (NYSE: CVM) Delayed: 1.14 +0.09 (8.57%)
Previous Close $1.05    52 Week High $0.66 
Open $1.06    52 Week Low $0.20 
Day High $1.17    P/E N/A 
Day Low $1.06    EPS $-0.34 
Volume 658,535